Reclast and Atrovent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Reclast (zoledronic acid) and Atrovent (ipratropium bromide). Common drug interactions include pneumonia among females and hospitalisation among males.

The phase IV clinical study analyzes what interactions people have when they take Reclast and Atrovent. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Reclast?

Reclast has active ingredients of zoledronic acid. It is often used in osteoporosis. eHealthMe is studying from 15,774 Reclast users. Check the latest studies of Reclast.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

63 people who take Reclast and Atrovent together, and have interactions are studied.

What are the common drug interactions of Reclast and Atrovent, by gender? *:

female:

Pneumonia
Poor quality sleep
Pulmonary oedema (fluid accumulation in the lungs)
Suicidal behaviour
Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection
Urticaria (rash of round, red welts on the skin that itch intensely)
Blood albumin decreased
Haematocrit decreased
Alopecia (absence of hair from areas of the body)

male:

Hospitalisation
Weight increased
Brain injury
Death
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Emotional disorder
Erectile dysfunction
Eye pain
Fluid retention (an abnormal accumulation of fluid in the blood)

What are the common drug interactions of Reclast and Atrovent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Decreased appetite
Fatigue (feeling of tiredness)
Infusion related reaction
Tremor (trembling or shaking movements in one or more parts of your body)
Mobility decreased (ability to move is reduced)

40-49:

Injection site bruising
Injection site haemorrhage (bleeding from injection site)

50-59:

Asthenia (weakness)
Foot fracture
Acute respiratory failure
Alanine aminotransferase increased
Anaemia (lack of blood)
Arthralgia (joint pain)
Aspartate aminotransferase increased
Aspergillus test positive
Blood calcium decreased
Blood creatinine increased

60+:

Headache (pain in head)
Cough
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Laryngitis (inflammation of the larynx)
Loss of proprioception (loss of senses of body and parts)
Nasal oedema (fluid collection in nose)
Nasal septum deviation (deviated nasal septum)
Nodule (a growth of abnormal tissue)

What are the existing conditions these people have? *

Asthma: 9 people, 14.29%
Pain: 9 people, 14.29%
Constipation: 9 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 14.29%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 8 people, 12.70%
Cough: 8 people, 12.70%
Bipolar Disorder (mood disorder): 6 people, 9.52%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 9.52%
High Blood Pressure: 6 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Reclast and Atrovent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously